Range Low Price High Price Comment
30 days $1.83 $2.57 Monday, 29th Apr 2024 CGEN stock ended at $1.98. This is 3.13% more than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 4.17% from a day low at $1.92 to a day high of $2.00.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Jan 15, 2021 $13.57 $14.22 $13.00 $13.01 1 134 512
Jan 14, 2021 $13.31 $13.98 $13.31 $13.51 1 249 276
Jan 13, 2021 $12.84 $13.75 $12.84 $13.41 1 368 394
Jan 12, 2021 $12.71 $12.93 $12.54 $12.81 867 841
Jan 11, 2021 $12.89 $12.96 $12.26 $12.62 1 360 047
Jan 08, 2021 $13.24 $14.30 $13.12 $13.32 2 077 751
Jan 07, 2021 $12.89 $13.58 $12.83 $13.23 1 147 889
Jan 06, 2021 $12.71 $13.22 $12.31 $12.52 1 080 674
Jan 05, 2021 $12.62 $12.90 $12.46 $12.66 839 711
Jan 04, 2021 $12.29 $12.93 $12.29 $12.76 1 024 480
Dec 31, 2020 $12.97 $13.10 $11.84 $12.11 1 526 914
Dec 30, 2020 $12.51 $13.28 $12.46 $12.91 1 218 400
Dec 29, 2020 $13.09 $13.21 $11.69 $12.37 1 257 131
Dec 28, 2020 $13.48 $13.88 $12.94 $12.97 1 719 144
Dec 24, 2020 $13.80 $14.49 $13.01 $13.13 1 018 157
Dec 23, 2020 $14.81 $14.94 $13.50 $13.51 1 660 292
Dec 22, 2020 $13.64 $15.16 $13.63 $14.19 2 868 374
Dec 21, 2020 $12.50 $14.08 $12.50 $13.56 2 010 429
Dec 18, 2020 $12.38 $13.10 $12.26 $12.67 1 266 960
Dec 17, 2020 $12.53 $12.69 $12.20 $12.30 935 300
Dec 16, 2020 $12.93 $13.27 $12.00 $12.07 1 448 301
Dec 15, 2020 $13.02 $13.24 $12.68 $13.02 1 053 036
Dec 14, 2020 $12.66 $13.60 $12.66 $12.92 1 458 657
Dec 11, 2020 $12.47 $12.84 $12.26 $12.44 1 353 719
Dec 10, 2020 $12.55 $12.79 $12.27 $12.48 1 141 305
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT